| Primary |
| Depression |
50.0% |
| Dyspepsia |
50.0% |
|
| Discomfort |
50.0% |
| Drug Interaction |
50.0% |
|
| Secondary |
| Product Used For Unknown Indication |
21.3% |
| Gastric Disorder |
9.8% |
| Gastric Polyps |
8.2% |
| Gastritis |
8.2% |
| Gastrooesophageal Reflux Disease |
8.2% |
| Depression |
6.6% |
| Emphysema |
4.9% |
| Glaucoma |
4.9% |
| Panic Disorder |
4.9% |
| Anticoagulant Therapy |
3.3% |
| Blood Triglycerides |
3.3% |
| Dyspepsia |
3.3% |
| Bacterial Infection |
1.6% |
| Diuretic Therapy |
1.6% |
| Hypertension |
1.6% |
| Prophylaxis |
1.6% |
| Psoriasis |
1.6% |
| Renal Cancer |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Tuberculosis |
1.6% |
|
| Ventricular Extrasystoles |
20.0% |
| Depression Suicidal |
10.0% |
| Drug Interaction |
10.0% |
| Multiple Drug Overdose |
10.0% |
| Respiratory Arrest |
10.0% |
| Tremor |
10.0% |
| Viral Infection |
10.0% |
| Vomiting |
10.0% |
| Weight Decreased |
10.0% |
|
| Concomitant |
| Prophylaxis |
18.8% |
| Product Used For Unknown Indication |
17.5% |
| Colorectal Cancer |
9.2% |
| Nausea |
8.9% |
| Drug Use For Unknown Indication |
5.9% |
| Vomiting |
5.6% |
| Hypertension |
3.4% |
| Pain Prophylaxis |
3.3% |
| Gastritis |
3.2% |
| Hiv Infection |
2.7% |
| Dyspepsia |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Anxiety |
2.3% |
| Pain |
2.2% |
| Prophylaxis Of Nausea And Vomiting |
2.2% |
| Gastric Disorder |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Infection |
2.0% |
| Infection Prophylaxis |
2.0% |
| Acute Coronary Syndrome |
1.9% |
|
| Vomiting |
11.9% |
| Fatigue |
9.9% |
| Renal Failure Acute |
7.9% |
| Pulmonary Embolism |
5.9% |
| Somnolence |
5.9% |
| Wound Dehiscence |
5.9% |
| Pneumonia |
5.0% |
| Vision Blurred |
5.0% |
| Weight Decreased |
5.0% |
| Hepatic Failure |
4.0% |
| Multi-organ Failure |
4.0% |
| Product Quality Issue |
4.0% |
| Syncope |
4.0% |
| Viral Infection |
4.0% |
| Osteoporosis |
3.0% |
| Pain |
3.0% |
| Pyrexia |
3.0% |
| Rash |
3.0% |
| Respiratory Failure |
3.0% |
| Stillbirth |
3.0% |
|
